Stelo: Personalizing Choices, Revolutionizing Glucose Health Presented by Patrick Welch, PharmD, BCACP

About the Webinar

In this 43-minute session, Patrick Welch, PharmD, BCACP, provides an introduction to Stelo and key takeways for pharmacists and other healthcare providers.  

Key Highlights:

[1:27] The Dexcom portfolio: Discover the differences between Dexcom G7 CGM and Stelo and how to choose the right product for your patients

[7:16] Glucose management matters: Explore why managing glucose levels is important for patients with type 2 diabetes and prediabetes

[13:14] Introducing Stelo: Learn about the innovative functionality of Stelo

[15:47] Case Study: Explore how Stelo impacts decision making and outcomes in a patient with type 2 diabetes

[17:18] Key Stelo features: Deep dive into Stelo's unique features and how they promote behavior change

[33:09] Emerging clinical evidence in T2D: Review recent evidence exploring how glucose monitoring can improve diabetes outcomes

[39:12] Getting started: Learn how to help patients get started on Stelo

About Stelo by Dexcom

Stelo marks a significant advancement in glucose monitoring. As the first FDA-cleared OTC glucose biosensor, it provides an option for those who do not have insurance coverage for CGM.  With Stelo, patients can monitor their glucose levels and time spent in their target range, enabling informed decisions about their health and lifestyle.

Learn More About Stelo

Don’t miss out on this valuable opportunity to enhance your practice and improve patient care. Learn more at Stelo.com.
 

^{Keywords: Stelo, glucose biosensor, glucose monitoring, prediabetes, type 2 diabetes, Dexcom, patient empowerment, primary care, glucose health webinar
MAT-7831}